瓣膜性心脏病管理的新策略：2020 年 ACC/AHA 瓣膜性心脏病患者管理指南十大要点的批判性评价。
New strategies in the management of valvular heart disease : A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease.
机构信息
Karl Landsteiner University of Health Sciences, Department of Internal Medicine 3, University Hospital St. Pölten, Krems, Austria, Dunant-Platz 1, 3100, St. Pölten, Austria.
出版信息
Wien Klin Wochenschr. 2021 Aug;133(15-16):786-789. doi: 10.1007/s00508-021-01879-y. Epub 2021 May 31.
PMID:34057577
Abstract
The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
摘要
经导管瓣膜病治疗技术的出现加速了心脏瓣膜病诊治研究的进展。该领域新的知识迅速积累，需要及时修订临床指南。本文就最近发表的美国心脏病学会/美国心脏协会（ACC/AHA）指南中涉及的一些重要和新颖的问题进行了评论。
相似文献
1
New strategies in the management of valvular heart disease : A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease.瓣膜性心脏病管理的新策略：2020 年 ACC/AHA 瓣膜性心脏病患者管理指南十大要点的批判性评价。
Wien Klin Wochenschr. 2021 Aug;133(15-16):786-789. doi: 10.1007/s00508-021-01879-y. Epub 2021 May 31.
2
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017年美国心脏协会/美国心脏病学会对2014年《美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南》的重点更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289. doi: 10.1016/j.jacc.2017.03.011. Epub 2017 Mar 15.
3
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.
4
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 10;129(23):e521-643. doi: 10.1161/CIR.0000000000000031. Epub 2014 Mar 3.
5
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南：执行摘要：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 10;129(23):2440-92. doi: 10.1161/CIR.0000000000000029. Epub 2014 Mar 3.
6
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2021 Feb 2;77(4):e25-e197. doi: 10.1016/j.jacc.2020.11.018. Epub 2020 Dec 17.
7
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南：执行摘要：美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17.
8
Perspective to 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients With Valvular Heart Disease.2020年美国心脏病学会/美国心脏协会（ACC/AHA）瓣膜性心脏病患者管理指南展望。
Circulation. 2021 Feb 2;143(5):407-409. doi: 10.1161/CIRCULATIONAHA.120.051501. Epub 2020 Dec 17.
9
2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南：执行摘要：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jun 10;63(22):2438-88. doi: 10.1016/j.jacc.2014.02.537. Epub 2014 Mar 3.
10
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017年美国心脏协会/美国心脏病学会对2014年《美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南》的重点更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2017 Jun 20;135(25):e1159-e1195. doi: 10.1161/CIR.0000000000000503. Epub 2017 Mar 15.
引用本文的文献
1
Shaping the Optimal Timing for Treatment of Isolated Asymptomatic Severe Aortic Stenosis with Preserved Left Ventricular Ejection Fraction: The Role of Non-Invasive Diagnostics Focused on Strain Echocardiography and Future Perspectives.确定左心室射血分数保留的孤立性无症状严重主动脉瓣狭窄的最佳治疗时机：聚焦应变超声心动图的非侵入性诊断作用及未来展望
J Imaging. 2025 Feb 8;11(2):48. doi: 10.3390/jimaging11020048.
本文引用的文献
1
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
J Am Coll Cardiol. 2021 Feb 2;77(4):450-500. doi: 10.1016/j.jacc.2020.11.035. Epub 2020 Dec 17.
2
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 10;129(23):e521-643. doi: 10.1161/CIR.0000000000000031. Epub 2014 Mar 3.
Zotero 插件